Alanis Therapeutics

Alanis Therapeutics, a spin out of the San Diego antibody engineering company AvantGen, is harnessing the potential of antibody-based therapeutics to target novel pathways and develop new agents to treat cancer and autoimmunity. Our lead product, ATI-D1, is an antibody that inhibits notch1 signaling between osteoblasts and leukemic stem cells-a key oncogenic driver of tumor progression in MDS/AML.

Return to previous page

Hello world!

November 20, 2023 /Posted byadmin / 336 / 1

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

About author

About Author

admin

One comment on “Hello world!”

A WordPress Commenter

November 20, 2023 - 7:04 am

Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.
Reply to comment

Developing BOLD New Antibody

Treatments for
Cancer and Autoimmune Diseases

Hello world!

Hello world!

About author

About Author

admin

One comment on “Hello world!”

A WordPress Commenter

Leave a reply Cancel reply

Recent Posts

Recent Comments